Comprehensive Genomic Investigation of Adaptive Mutations Driving the Low-Level Oxacillin Resistance Phenotype in Staphylococcus aureus.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
08 12 2020
Historique:
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 8 9 2021
Statut: epublish

Résumé

Antistaphylococcal penicillins such as oxacillin are the key antibiotics in the treatment of invasive methicillin-susceptible

Identifiants

pubmed: 33293382
pii: mBio.02882-20
doi: 10.1128/mBio.02882-20
pmc: PMC7733948
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Oxacillin UH95VD7V76

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Giulieri et al.

Références

Genome Med. 2018 Aug 23;10(1):65
pubmed: 30103826
Microb Genom. 2019 Jan;5(1):
pubmed: 30663960
J Clin Microbiol. 2014 Aug;52(8):3114-7
pubmed: 24850355
Biochemistry. 2012 Feb 14;51(6):1199-212
pubmed: 22257032
Microb Drug Resist. 2019 Dec;25(10):1401-1409
pubmed: 31329022
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Microb Genom. 2015 Aug 3;1(2):e000026
pubmed: 28348811
Mol Ecol Resour. 2018 Jul;18(4):755-766
pubmed: 29504715
Clin Infect Dis. 2003 Jan 1;36(1):53-9
pubmed: 12491202
Bioinformatics. 2018 Nov 1;34(21):3711-3718
pubmed: 29757357
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29661881
J Med Microbiol. 2017 Oct;66(10):1367-1373
pubmed: 28893360
Clin Microbiol Infect. 2013 May;19(5):465-71
pubmed: 22616816
PLoS Pathog. 2012;8(4):e1002626
pubmed: 22496652
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Bioinformatics. 2018 Dec 15;34(24):4310-4312
pubmed: 30535304
Expert Rev Anti Infect Ther. 2016 Nov;14(11):1023-1036
pubmed: 27626511
J Antimicrob Chemother. 2016 Jan;71(1):34-40
pubmed: 26483514
J Infect Dis. 2011 Aug 1;204(3):340-7
pubmed: 21742831
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Nat Rev Microbiol. 2013 Aug;11(8):513-24
pubmed: 23812326
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
J Antimicrob Chemother. 2014 Mar;69(3):594-7
pubmed: 24216768
Antimicrob Agents Chemother. 1989 Nov;33(11):1869-74
pubmed: 2610497
Infect Immun. 2018 Sep 21;86(10):
pubmed: 30061376
J Bacteriol. 2005 May;187(10):3455-64
pubmed: 15866932
PeerJ. 2017 Feb 28;5:e3047
pubmed: 28265515
BMC Infect Dis. 2018 Mar 5;18(1):107
pubmed: 29506483
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28717043
Arch Microbiol. 2005 Nov;184(2):117-28
pubmed: 16177891
Microb Drug Resist. 2005 Spring;11(1):78-81
pubmed: 15770100
Antimicrob Agents Chemother. 2008 Oct;52(10):3755-62
pubmed: 18644967
Antimicrob Agents Chemother. 2012 Jan;56(1):579-81
pubmed: 21986827
Antimicrob Agents Chemother. 2014 Aug;58(8):4593-603
pubmed: 24867990
J Med Microbiol. 2006 Dec;55(Pt 12):1675-1683
pubmed: 17108271
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
Mol Microbiol. 2005 Aug;57(3):717-26
pubmed: 16045616
Clin Infect Dis. 2011 Jun;52 Suppl 7:S487-92
pubmed: 21546625
J Clin Microbiol. 2009 Mar;47(3):859-61
pubmed: 19116360
PLoS Pathog. 2011 Sep;7(9):e1002217
pubmed: 21909268
PLoS Genet. 2017 Feb 16;13(2):e1006508
pubmed: 28207813
Antimicrob Agents Chemother. 1990 May;34(5):728-32
pubmed: 2360813
J Infect Dis. 1988 Oct;158(4):702-9
pubmed: 3049836
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
J Antimicrob Chemother. 2014 Aug;69(8):2065-75
pubmed: 24777906
Stand Genomic Sci. 2015 Nov 20;10:109
pubmed: 26594310
Nat Rev Genet. 2017 Jan;18(1):41-50
pubmed: 27840430
Antimicrob Agents Chemother. 2013 Jan;57(1):83-95
pubmed: 23070169
J Antimicrob Chemother. 2019 May 1;74(5):1182-1191
pubmed: 30759229
Nat Rev Microbiol. 2016 Jan;14(1):33-44
pubmed: 26639779
Infect Control Hosp Epidemiol. 1991 Jan;12(1):14-9
pubmed: 1900315
Antimicrob Agents Chemother. 2010 Nov;54(11):4900-2
pubmed: 20805396
PLoS Pathog. 2019 Sep 13;15(9):e1008044
pubmed: 31518377
Antimicrob Agents Chemother. 2015 May;59(5):2799-806
pubmed: 25733508
Antimicrob Agents Chemother. 1995 Jan;39(1):103-6
pubmed: 7695289
PLoS One. 2018 Jul 3;13(7):e0199707
pubmed: 29969476
PLoS Pathog. 2020 Jul 24;16(7):e1008672
pubmed: 32706832
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
mSphere. 2018 Jan 24;3(1):
pubmed: 29404415
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Clin Microbiol. 1986 May;23(5):832-9
pubmed: 3011847
Mol Microbiol. 2003 Jun;48(6):1565-78
pubmed: 12791139
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Antimicrob Chemother. 2014 Dec;69(12):3190-8
pubmed: 25103491
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20135-20140
pubmed: 31527262
Mol Microbiol. 2004 Dec;54(5):1445-62
pubmed: 15554981
mBio. 2015 May 26;6(3):e00308-15
pubmed: 26015493

Auteurs

Stefano G Giulieri (SG)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, Austin Health, Heidelberg, Australia.

Romain Guérillot (R)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Jason C Kwong (JC)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, Austin Health, Heidelberg, Australia.

Ian R Monk (IR)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Ashleigh S Hayes (AS)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Diane Daniel (D)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Sarah Baines (S)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Norelle L Sherry (NL)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.
Department of Infectious Diseases, Austin Health, Heidelberg, Australia.
Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Natasha E Holmes (NE)

Department of Infectious Diseases, Austin Health, Heidelberg, Australia.

Peter Ward (P)

Department of Microbiology, Austin Health, Heidelberg, Australia.

Wei Gao (W)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Torsten Seemann (T)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.
Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Timothy P Stinear (TP)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Benjamin P Howden (BP)

Department of Microbiology and Immunology, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia bhowden@unimelb.edu.au.
Department of Infectious Diseases, Austin Health, Heidelberg, Australia.
Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH